We are live on
!
Find out more
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
49 hedge funds and large institutions have $508M invested in Evelo Biosciences, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 8
141% more capital invested
Capital invested by funds: $211M → $508M (+$298M)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
13% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 8
2% more funds holding
Funds holding: 48 → 49 (+1)
Holders
49
Holders Change
+1
Holders Change %
+2.08%
% of All Funds
0.87%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.07%
New
9
Increased
24
Reduced
8
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.1M |
| 2 |
BlackRock
New York
|
+$2.24M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.65M |
| 4 |
AG
Artal Group
Luxembourg
|
+$1.39M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$1.21M |
